ANLN and adrenal cortex carcinoma: The data indicated that high expression of ANLN was significantly associated with poor OS for patients with ACC (HR = 1.04, P < 0.001), BLCA (HR = 1.01, P < 0.001), CESC (HR = 1.01, P = 0.002), CHOL (HR = 1.05, P = 0.042), KICH (HR = 1.12, P < 0.001), KIRC (HR = 1.03, P < 0.001), KIRP (HR = 1.1, P < 0.001), LIHC (HR = 1.04, P < 0.001), LUAD (HR = 1.01, P < 0.001), MESO (HR = 1.02, P < 0.001), PAAD (HR = 1.03, P < 0.001), and UVM (HR = 1.53, P < 0.001).